Based on the bulk density after premixing, the three batches of validation conducted by Sandia Pharmaceutical Technology Co., Ltd. transferred to Shanghai Ellis Pharmaceutical Technology Co., Ltd. are about 50%, the clinical batches produced by Jiangsu wangao Pharmaceutical Co., Ltd. are 34%, and the clinical batches produced by Shanghai xuantai Haimen Pharmaceutical Co., Ltd. are about 47%.
正在翻译中..